Implementation Challenges and Pathways for Advance Distribution of Misoprostol for Postpartum Haemorrhage Prevention in Nigeria: A Qualitative Political Economy Analysis
Abstract Background Postpartum haemorrhage (PPH) is a leading cause of maternal mortality in Nigeria, where the maternal mortality ratio is approximately 993 deaths per 100,000 live births and, in 17 of 36 states, more than half of births occur outside a facility. Advance distribution of misoprostol for use after home birth is recommended by WHO and authorised by Nigeria’s National guidelines for the use of misoprostol for the prevention of postpartum haemorrhage (2023) yet is not implemented at scale in any state. Methods We examined the structural and behavioural factors shaping this policy-implementation gap at national level (in the Federal Capital Territory) and in three purposively selected states (Sokoto, Niger, and Akwa Ibom) Forty-eight key informant interviews and four stakeholder roundtables conducted between 25 August and 10 September 2025.were analysed thematically using a codebook guided by the Context and Implementation of Complex Interventions framework and the Capability–Opportunity–Motivation–Behaviour model, interpreted through a political economy analysis lens. Reporting follows the Standards for Reporting Qualitative Research. Results No participant contested misoprostol’s effectiveness; the gap reflected interacting structural and behavioural factors. Structural barriers included regulatory ambiguity, weak federal-to-state translation, fragmented supply, donor dependence, and absent community-level pharmacovigilance. Behavioural readiness differed by state: Sokoto strongest from prior pilot exposure, Niger with latent capacity but no operational pathway, and Akwa Ibom with misoprostol stock at health facilities but low awareness of strategies to extend uterotonic coverage to community births. Stakeholders identified six interrelated pathways to close the policy-implementation gap and promote uptake of advance distribution of misoprostol spanning policy alignment, model adaptation, health-system support, demand creation, financing, and operational learning. Conclusion The gap is operational, regulatory, and behavioural. Closing it requires federal regulatory clarification, state-led adaptation of the national guideline through inclusive coordination platforms, and integration of advance distribution of misoprostol into routine financing, supply, workforce, and monitoring systems.
Authors
- Aisha Nana Adamu (ORCID: https://orcid.org/0000-0002-6330-1033)
- Pooja Sripad (ORCID: https://orcid.org/0000-0002-1166-5564)
- Victor Abiola Adepoju (ORCID: https://orcid.org/0000-0001-8379-1001)
- Hannah Tappis (ORCID: https://orcid.org/0000-0002-4289-5418)
- Elaine Roman (ORCID: https://orcid.org/0000-0001-8381-1885)
- Bright Orji (ORCID: https://orcid.org/0000-0001-7679-0879)
- S Kailani
- Freda Kalema Nyaga
- Sefunmi Oluwole
- Samuel Oyeniyi
- Sylverius Obafemi (ORCID: https://orcid.org/0009-0007-6597-4892)
- Adetiloye Oniyire
Institutions
- Federal Ministry of Health (NG)
- Federal University Birnin Kebbi (NG)
- Jhpiego (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11158050/v1
- Primary Topic
- Health Policy Implementation Science
- Type
- preprint
Funders
- European Commission